CAR‐NK cell in cancer immunotherapy; A promising frontier F Marofi, OF Abdul‐Rasheed, HS Rahman, HS Budi, AT Jalil, ... Cancer Science 112 (9), 3427-3436, 2021 | 210 | 2021 |
CAR T cells targeting the tumor MUC1 glycoprotein reduce triple-negative breast cancer growth R Zhou, M Yazdanifar, LD Roy, LM Whilding, A Gavrill, J Maher, ... Frontiers in immunology 10, 1149, 2019 | 167 | 2019 |
γδ T Cells: The Ideal Tool for Cancer Immunotherapy M Yazdanifar, G Barbarito, A Bertaina, I Airoldi Cells 9 (5), 1305, 2020 | 139 | 2020 |
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies E Razeghian, MKM Nasution, HS Rahman, ZR Gardanova, ... Stem cell research & therapy 12, 1-17, 2021 | 116 | 2021 |
RETRACTED: CAR-NK cell: a new paradigm in tumor immunotherapy F Marofi, AS Al-Awad, H Sulaiman Rahman, A Markov, WK Abdelbasset, ... Frontiers in oncology 11, 673276, 2021 | 97 | 2021 |
Engineering the Bridge between Innate and Adaptive Immunity for Cancer Immunotherapy: Focus on γδ T and NK Cells F Morandi*, M Yazdanifar*, C Cocco, A Bertaina, I Airoldi Cells 9 (8), 1757, 2020 | 80 | 2020 |
A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis R Zhou, JM Curry, LD Roy, P Grover, J Haider, LJ Moore, ST Wu, ... Oncogene 35 (43), 5608-5618, 2016 | 69 | 2016 |
CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies F Marofi, MM Saleh, HS Rahman, W Suksatan, ME Al-Gazally, ... Stem cell research & therapy 12 (1), 374, 2021 | 64 | 2021 |
Overcoming Immunological Resistance Enhances the Efficacy of a Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic Ductal Adenocarcinoma M Yazdanifar, R Zhou, P Grover, C Williams, M Bose, LJ Moore, S Wu, ... Cells 8 (9), 1070, 2019 | 61 | 2019 |
RETRACTED: A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions F Marofi, HS Rahman, MH Achmad, KN Sergeevna, W Suksatan, ... Frontiers in immunology 12, 681984, 2021 | 50 | 2021 |
Hurdles to breakthrough in CAR T cell therapy of solid tumors F Marofi, H Achmad, D Bokov, WK Abdelbasset, Z Alsadoon, S Chupradit, ... Stem Cell Research & Therapy 13 (1), 140, 2022 | 44 | 2022 |
RETRACTED: Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges E Razeghian, W Suksatan, H Sulaiman Rahman, DO Bokov, ... Frontiers in immunology 12, 699746, 2021 | 42 | 2021 |
Evaluation of cytokines in multiple sclerosis patients treated with mesenchymal stem cells MM Bonab, M Mohajeri, MA Sahraian, M Yazdanifar, A Aghsaie, ... Archives of Medical Research 44 (4), 266-272, 2013 | 41 | 2013 |
Induced pluripotent stem cells (iPSCs) provide a potentially unlimited T cell source for CAR-T cell development and off-the-shelf products M Sadeqi Nezhad, M Abdollahpour-Alitappeh, B Rezaei, M Yazdanifar, ... Pharmaceutical Research 38 (6), 931-945, 2021 | 34 | 2021 |
Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles S Wu, AJ Fowler, CB Garmon, AB Fessler, JD Ogle, KR Grover, BC Allen, ... BMC cancer 18, 1-13, 2018 | 34 | 2018 |
Antibody-guided in vivo imaging for early detection of mammary gland tumors LJ Moore, LD Roy, R Zhou, P Grover, S Wu, JM Curry, LM Dillon, PM Puri, ... Translational Oncology 9 (4), 295-305, 2016 | 31 | 2016 |
RETRACTED: Mesenchymal Stem/Stromal Cells as a Vehicle for Cytokine Delivery: An Emerging Approach for Tumor Immunotherapy E Razeghian, R Margiana, S Chupradit, DO Bokov, WK Abdelbasset, ... Frontiers in medicine 8, 721174, 2021 | 30 | 2021 |
Making a case for using γδ T cells against SARS-CoV-2 M Yazdanifar, N Mashkour, A Bertaina Critical Reviews in Microbiology 46 (4), 2020 | 25 | 2020 |
Strengthening the CAR‐T cell therapeutic application using CRISPR/Cas9 technology M Sadeqi Nezhad, M Yazdanifar, M Abdollahpour‐Alitappeh, A Sattari, ... Biotechnology and Bioengineering 118 (10), 3691-3705, 2021 | 24 | 2021 |
RETRACTED: Mesenchymal Stem/Stromal Cell-Based Delivery: A Rapidly Evolving Strategy for Cancer Therapy A Hassanzadeh, AH Altajer, HS Rahman, MM Saleh, DO Bokov, ... Frontiers in Cell and Developmental Biology 9, 686453, 2021 | 23 | 2021 |